Blurbs

Analysts Offer Insights on Healthcare Companies: Prothena (PRTA) and Beauty Health (SKIN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Prothena (PRTAResearch Report) and Beauty Health (SKINResearch Report) with bullish sentiments.

Prothena (PRTA)

RBC Capital analyst Brian Abrahams maintained a Buy rating on Prothena today and set a price target of $52.00. The company’s shares closed last Tuesday at $30.93.

According to TipRanks.com, Abrahams is a 4-star analyst with an average return of 2.2% and a 45.8% success rate. Abrahams covers the Healthcare sector, focusing on stocks such as Intra-Cellular Therapies, Karyopharm Therapeutics, and Enanta Pharmaceuticals.

Prothena has an analyst consensus of Strong Buy, with a price target consensus of $68.25, representing a 135.3% upside. In a report released today, JMP Securities also reiterated a Buy rating on the stock with a $81.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Beauty Health (SKIN)

In a report released today, Linda Bolton Weiser from D.A. Davidson maintained a Buy rating on Beauty Health, with a price target of $31.00. The company’s shares closed last Tuesday at $11.58, close to its 52-week low of $9.95.

According to TipRanks.com, Weiser is a 3-star analyst with an average return of 1.2% and a 45.8% success rate. Weiser covers the Consumer Goods sector, focusing on stocks such as The Estée Lauder Companies, Waldencast Acquisition, and Lifetime Brands.

Beauty Health has an analyst consensus of Strong Buy, with a price target consensus of $22.63, implying a 97.5% upside from current levels. In a report issued on September 15, J.P. Morgan also maintained a Buy rating on the stock with a $22.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on PRTA:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More